Open Access iconOpen Access

ARTICLE

crossmark

Long-Term Outcome and Risk Factor Analysis of Surgical Pulmonary Valve Replacement in Congenital Heart Disease

by Woo Young Park1, Gi Beom Kim1,*, Sang Yun Lee1, Mi Kyoung Song1, Hye Won Kwon1, Hyo Soon An1, Eun Jung Bae1, Sungkyu Cho2, Jae Gun Kwak2, Woong-Han Kim2

1 Department of Pediatrics, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea
2 Department of Thoracic and Cardiovascular Surgery, Seoul National University Children’s Hospital, Seoul National University College of Medicine, Seoul, Korea

* Corresponding Author: Gi Beom Kim. Email: email

Congenital Heart Disease 2022, 17(3), 335-350. https://doi.org/10.32604/chd.2022.018666

Abstract

Objectives: To establish long-term outcome of surgical pulmonary valve replacement (PVR) in congenital heart disease (CHD) and to identify risk factors for overall mortality, operative mortality, and repetitive PVR. Methods: This is a retrospective study of 375 surgical PVR in 293 patients who underwent surgical PVR for CHD between January 2000 and May 2020. We only included patients with index PVR with previous open-heart surgery regardless of the number of PVRs. The previous surgical history of patients who underwent PVR during the study period was also included. Patients who underwent the Rastelli operation, and those who underwent single PVR without previous open-heart surgery were excluded. Results: The median age of the patients at the time of surgical PVR was 14.9 years (Interquartile range, IQR, 11.0–22.0). The median follow-up duration was 10.5 years (IQR, 5.5–14.8 years). There were 3 patients with operative mortality (1.0%) and 15 patients with overall mortality (5.1%). The survival rate was 95.1% over 20 years follow-up period. Multivariate analysis demonstrated that more than 3 times of previous open-heart surgeries before surgical PVR, older age at the first operation, longer cardiopulmonary bypass (CPB) time and longer intensive care unit (ICU) stay were predictors for overall mortality. Patients who underwent surgical PVR after more than 3 times of previous open-heart surgeries had significantly higher mortality than those who underwent open-heart surgeries less than 3 times (P < 0.001). Age younger than 10 years, male, multiple valve problems and longer ICU stay were significant predictors for repetitive PVR by multivariate analysis. Conclusions: Though surgical PVR has excellent long-term outcome, it should be performed with caution for those who previously underwent multiple open-heart surgeries, especially if patient received more than 3 times of open-heart surgeries.

Keywords


Cite This Article

APA Style
Park, W.Y., Kim, G.B., Lee, S.Y., Song, M.K., Kwon, H.W. et al. (2022). Long-term outcome and risk factor analysis of surgical pulmonary valve replacement in congenital heart disease. Congenital Heart Disease, 17(3), 335-350. https://doi.org/10.32604/chd.2022.018666
Vancouver Style
Park WY, Kim GB, Lee SY, Song MK, Kwon HW, An HS, et al. Long-term outcome and risk factor analysis of surgical pulmonary valve replacement in congenital heart disease. Congeni Heart Dis. 2022;17(3):335-350 https://doi.org/10.32604/chd.2022.018666
IEEE Style
W. Y. Park et al., “Long-Term Outcome and Risk Factor Analysis of Surgical Pulmonary Valve Replacement in Congenital Heart Disease,” Congeni. Heart Dis., vol. 17, no. 3, pp. 335-350, 2022. https://doi.org/10.32604/chd.2022.018666



cc Copyright © 2022 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 1770

    View

  • 727

    Download

  • 0

    Like

Share Link